Nephrology/pediatric nephrology

August 1997
Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS62
Academic Journal
Presents an abstract of the research manuscript `Urea clearance, protein metabolism, and dialysis adequacy in CAPD-treated chronic renal failure,' by M.A. Baltzan et al.


Related Articles

  • New labeling for epogen increases target range of RBC. Hurley, Mary Lou // RN;Jun95, Vol. 58 Issue 6, p67 

    Reports that the upper target hematocrit range for dialysis patients who receive epoetin alfa (Epogen) has been increased from 33 to 36%. Studies which show an increased hematocrit improves chronic renal failure patients' quality of life; Revised package labeling.

  • Haemodialysis adequacy: looking for the holy grail. White, Yvonne // Renal Society of Australasia Journal;Jul2013, Vol. 9 Issue 2, p94 

    Goal: To review haemodialysis adequacy assessment. Objectives: • To define haemodialysis adequacy. • To critique current measures of haemodialysis adequacy. • To identify major clinical issues related to haemodialysis adequacy assessment in haemodialysis.

  • Pediatric dialysis and renal transplantation in Kuwait over the past 11 years. El-Reshaid, K.; Kapoor, Madan M.; Naryanan Nampoory, M. R.; El-Reshaid, W.; Johny, Kaivilayil V. // Pediatric Nephrology;1999, Vol. 13 Issue 3, p259 

    Data on end-stage renal disease (ESRD) patients and their renal replacement therapy (RRT) were collected retrospectively from the three dialysis centers, the pediatric urology unit, and the organ transplant center of Kuwait. The study period was from 1 January 1986 to 31 December 1996. A total...

  • Adalimumab Monotherapy in a Patient with Psoriatic Arthritis Associated with Chronic Renal Failure on Hemodialysis: A Case Report and Literature Review. Yasuhiro Shimojima; Masayuki Matsuda; Wataru Ishii; Shu-ichi Ikeda // Clinical Medicine Insights: Case Reports;2012, Issue 5, p13 

    We report a patient with psoriatic arthritis (PsA) who was successfully treated with adalimumab even while under hemodialysis therapy for associated chronic renal failure. Flow cytometry of circulating lymphocytes revealed an obvious decrease in both Th1 and Th17 cells after starting adalimumab....

  • Clinical Outcomes of Nocturnal Dialysis. Sherer, Maria // Nephrology Nursing Journal;Oct2002, Vol. 29 Issue 5, p487 

    Presents a case study which examined the clinical outcomes of nocturnal dialysis on a patient with end stage renal disease. Description of the clinical background of the patient; Overview of the intended patient outcomes of nocturnal dialysis; Method for achieving anticoagulation in dialyzers.

  • Renal replacement therapy: how far have we come? Noble, Helen // British Journal of Nursing;1/26/2012, Vol. 21 Issue 2, p74 

    In this article the author reflects on advances which have been made in renal replacement therapy which features dialysis. She suggests that while improvement have been made to renal replacement therapy, dialysis remains an arduous and difficult therapy which can have serious consequences on...

  • No advantage for early vs late start to dialysis, says IDEAL trial. Lyon, Sue // British Journal of Hospital Medicine (17508460);Sep2010, Vol. 71 Issue 9, p490 

    The article reports on a randomized clinical trial of early versus late initiation of dialysis conducted by Bruce Cooper and colleagues. Result showed that starting dialysis early neither improves survival nor reduces complications in patients with end-stage renal disease. It also found that...

  • Kidneys from cadavers.  // British Medical Journal;1/22/1977, Vol. 1 Issue 6055, p188 

    Reports the use of kidneys from cadavers for transplantation to patients with chronic renal failure in Great Britain. Cost of dialysis; Difficulty in the removal of the kidney after death; Public attitudes to kidney transplantation.

  • Kt/V urea does not tell it all. Basile, Carlo; Lomonte, Carlo // Nephrology Dialysis Transplantation;Apr2012, Vol. 27 Issue 4, p1284 

    No abstract available.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics